Enanta Pharmaceuticals | Pre Utilidad Fiscal



Pre Tax Profit Cambio Fecha
AbbVie USD 4.81B 1.54B 2024-12
Amgen USD 3.38B 111M 2024-12
Arrowhead Research USD 369.62M 544.73M 2025-03
AstraZeneca USD 3.4B 1.74B 2025-03
Biogen USD 572.2M 118.5M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
Halozyme Therapeutics USD 557.13M 359.8M 2024-12
Incyte USD 234.19M 172.64M 2025-03
Insmed USD -255671000 21.39M 2025-03
Ionis Pharmaceuticals USD -147000000 40M 2025-03
J&J USD 13.63B 8.21B 2025-03
Ligand Pharmaceuticals USD -50180000 66.18M 2025-03
Merck USD 5.22B 114M 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Enanta Pharmaceuticals Pre Utilidad Fiscal - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jun 2025.